1-4 of 4
Garrett M. Frampton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

Free
Paul Riviere, Aaron M. Goodman, Ryosuke Okamura, Donald A. Barkauskas, Theresa J. Whitchurch, Suzanna Lee, Noor Khalid, Rachel Collier, Manvita Mareboina, Garrett M. Frampton, David Fabrizio, Andrew B. Sharabi, Shumei Kato, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (10): 2139–2145.
https://doi.org/10.1158/1535-7163.MCT-20-0161
Published: 02 October 2020
View article titled, High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers
Open the PDF for High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers in another window
Includes: Supplementary data
Journal Articles

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Free
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip P. Patel, Garrett M. Frampton, Vincent Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (11): 2598–2608.
https://doi.org/10.1158/1535-7163.MCT-17-0386
Published: 01 November 2017
View article titled, Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Open the PDF for Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract A79: Comprehensive genomic profiling (CGP) of adult granulosa cell tumors (aGCT) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options

Free
Michelle Rowland, Scott McMeekin, Kathleen Moore, Mark Bailey, Siraj M. Ali, Rosemary Zuna, Jo-Anne Vergilio, James Suh, Juliann Chmielecki, Garrett M. Frampton, Doron Lipson, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross, Julia A. Elvin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A79.
https://doi.org/10.1158/1535-7163.TARG-15-A79
Published: 01 December 2015
View article titled, Abstract A79: Comprehensive genomic profiling (CGP) of adult granulosa cell tumors (aGCT) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options
Journal Articles

Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer

Free
Funda Meric-Bernstam, Garrett M. Frampton, Jaime Ferrer-Lozano, Roman Yelensky, Jose A. Pérez-Fidalgo, Ying Wang, Gary A. Palmer, Jeffrey S. Ross, Vincent A. Miller, Xiaoping Su, Pilar Eroles, Juan Antonio Barrera, Octavio Burgues, Ana M. Lluch, Xiaofeng Zheng, Aysegul Sahin, Philip J. Stephens, Gordon B. Mills, Maureen T. Cronin, Ana M. Gonzalez-Angulo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (5): 1382–1389.
https://doi.org/10.1158/1535-7163.MCT-13-0482
Published: 05 May 2014
View article titled, Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer
Open the PDF for Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer in another window
Includes: Supplementary data